Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10016124HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10004445HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10026818HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10025174HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10026819HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10035476HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS10026820HBVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS30085899HIVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS30032215HIVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20008358HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TCGA Plot Options
Drug Information
GeneGRIN2B
DrugBank IDDB06077
Drug NameLumateperone
Target IDBE0000417
UniProt IDQ13224
Regulation Type
PubMed IDs30449883
CitationsVanover KE, Davis RE, Zhou Y, Ye W, Brasic JR, Gapasin L, Saillard J, Weingart M, Litman RE, Mates S, Wong DF: Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia. Neuropsychopharmacology. 2019 Feb;44(3):598-605. doi: 10.1038/s41386-018-0251-1. Epub 2018 Oct 26.
GroupsApproved; Investigational
Direct ClassificationAlkyl-phenylketones
SMILES[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C
Pathways
PharmGKB
ChEMBLCHEMBL3306803